🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 3 of 757 · Phase 3 first, then by program name

  1. 1:1:1 Blood Transfusion Ratio

    United Therapeutics Europe Ltd

    Trauma

    phase 3 mab completed

    1 trial

  2. 1mg elsunersen

    PRECISION BIOSCIENCES INC

    Epileptic Encephalopathy

    phase 3 small molecule active

    1 trial

  3. 2 cycles induction chemotherapy

    First Tracks Biotherapeutics

    Locally Advanced Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  4. 2 mg Melatonin

    United Therapeutics Europe Ltd

    Anxiety

    phase 3 small molecule completed

    1 trial

  5. 2-mg Intravitreous Aflibercept Injection

    Regeneron UK Limited

    Proliferative Diabetic Retinopathy

    phase 3 small molecule completed

    1 trial

  6. 2.0 mg intravitreal aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 3 small molecule completed

    1 trial

  7. 20 mg VEC-162

    Vanda Pharmaceuticals Netherlands B.V.

    Insomnia

    phase 3 small molecule completed

    1 trial

  8. 20 mg sildenafil citrate by mouth

    First Tracks Biotherapeutics

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  9. 20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks

    PRECISION BIOSCIENCES INC

    Focal Seizure

    phase 3 small molecule active

    1 trial

  10. 25 mg Ontamalimab

    Takeda Pharmaceuticals International AG

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  11. 2mg Baricitinib

    China SXT Pharmaceuticals

    Acute Ichemic Stroke

    phase 3 small molecule active

    1 trial

  12. 3-N-butylphthalide

    First Tracks Biotherapeutics

    Multiple System Atrophy

    phase 3 small molecule active

    1 trial

  13. 3-dimensional conformal radiation therapy

    United Therapeutics Europe Ltd

    Head and Neck Cancer

    phase 3 other active

    1 trial

  14. 35 mg oral lyophilisate, 25 mg oral lyophilisate, 50 mg oral lyophilisate, VYDURA 75 mg oral lyophilisate

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Acute Migraine (with or without aura)

    phase 3 small molecule active

    1 trial

  15. 36-71 months old children-experimental EV71 vaccine.

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  16. 4-aminopyridine

    United Therapeutics Europe Ltd

    Spinal Muscular Atrophy

    phase 3 small molecule completed

    1 trial

  17. 40 mg/day vormatrogine for 12 weeks

    PRECISION BIOSCIENCES INC

    Focal Epilepsy

    phase 3 small molecule active

    1 trial

  18. 400U /0.5ml EV71 vaccine

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  19. 4D-150 IVT (3E10 vg/eye)

    4D Molecular Therapeutics

    Macular Neovascularization Secondary to Age-Related Macular Degeneration

    phase 3 mab active

    1 trial

  20. 4D-150 IVT (3E10 vg/eye)

    4D Molecular Therapeutics

    Neovascular Age-Related Macular Degeneration (nAMD)

    phase 3 mab active

    1 trial

  21. 5 mg Serlopitant Tablets

    VYNE Therapeutics

    Pruritus

    phase 3 small molecule terminated

    3 trials

  22. 5 mg prednisone

    Ultragenyx UK Limited

    Granulomatosis With Polyangiitis

    phase 3 small molecule active

    2 trials

  23. 5% Dextrose injection; Solution for injection/infusion, OPDIVO 10 mg/mL concentrate for solution for infusion., 0.9% Sodium Chloride injection; Solution for injection/infusion

    Bristol-Myers Squibb / Pfizer EEIG

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  24. 5% Lidocaine patch

    China SXT Pharmaceuticals

    Herpes Zoster Pain

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources